Skip to content

Introduction of a simplified retrospectively collectable version of an internationally established frailty score (the Clinical Frailty Scale, abbreviated CFS) for geriatric intensive care patients (Very old Intensive care Patients, abbreviated VIP)

Introduction of a simplified retrospectively collectable version of an internationally established frailty score (the Clinical Frailty Scale, abbreviated CFS) for geriatric intensive care patients (Very old Intensive care Patients, abbreviated VIP)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035881
Enrollment
170
Registered
2025-01-22
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R54

Interventions

Group 1: Geriatric intensive care patients (age at least 65 years, ICU-length of stay at least 72 hours)

Sponsors

Klinik für Anästhesiologie, Universitätsmedizin Mainz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients of the anesthesia intensive care unit of the University Medical Center Mainz between 01.01.-31.12.2020 - ICU stay of at least 3 days (72 hours)

Exclusion criteria

Exclusion criteria: - ICU stay <72 hours - Incomplete admission scores (SAPS, TISS28 and SOFA) for the first 72 hours of the respective ICU stay

Design outcomes

Primary

MeasureTime frame
Inter-rater reliability of the Clinical Frailty Scale (CFS), which is determined discretely (scale value 1-9) and categorically (A = non frail = CFS 1-3; B = vulnerable = CFS =4; C = frail = CFS >4) by 3 independent raters using defined sources to be used

Secondary

MeasureTime frame
Secondary efficacy data with influence on mortality (1. ICU mortality, 2. 30-day mortality): Patient age, SOFA, TISS28, SAPS, Charlson Comorbidity Index (CCI), case-mix score of disease severity, ICU bed days, hospital bed days, ventilator hours, readmission to ICU 48h, COVID, Was an advance directive in place?, Was a DNR agreement in place? BMI, ASA (first ASA score; only available for surgical patients), surgery, organ replacement in ICU (invasive ventilation, renal replacement therapy, transfusion), complications in ICU (re-intubation, CPR, ICB, stroke), laboratory parameters in ICU (lactate, PCT) - Treatment goal discussions: Did discussions take place regularly, promptly, interdisciplinary, interprofessional? 1. when was the first discussion, 2. when was therapy limitation/termination, 3. how long did patients remain in the ICU in this case? Correlations/dependencies with independent variables (e.g. tumor yes/no, age 65-80 vs. >80, CFS fit vs. frail, SOFA severe vs. less severely ill, organ insufficiency)

Countries

Germany

Contacts

Public ContactMichael Schuster

Klinik für Anästhesiologie, Universitätsmedizin Mainz

michael.schuster@unimedizin-mainz.de+49 6131 175987

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026